Skip to main content
Access Bio, Inc. logo

Access Bio, Inc. — Investor Relations & Filings

Ticker · 950130 ISIN · KR8840090003 LEI · 335800Q5TV77F4L9Q648 KO Manufacturing
Open in API
Filings indexed 248 across all filing types
Latest filing 2026-05-15 Interim / Quarterly Rep…
Country IN India
Listing KO 950130

About Access Bio, Inc.

https://accessbio.net/

Access Bio, Inc. is a company dedicated to the prevention and early diagnosis of infectious diseases through the research, development, and manufacturing of in vitro diagnostic solutions. Its portfolio includes rapid diagnostic tests (RDTs), immunochemical diagnostics, biosensors, and molecular diagnostic products. The company is recognized for commercializing high-quality tests to combat significant global health threats, including malaria, COVID-19, HIV, and HPV. With a large-scale manufacturing capacity, Access Bio distributes its products globally, serving as a key partner in global health, particularly in the fight against often-neglected diseases.

Recent filings

Filing Released Lang Actions
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 98% confidence The document is clearly titled “분기보고서” (Quarterly Report) for the 25th fiscal period, covering actual financial data and business narrative for the quarter (January 1 to March 31, 2026). It contains detailed financial statements, business overviews, production tables, and management discussion typical of an interim/quarterly report. Therefore, it fits the definition of Interim / Quarterly Report (Code: IR). Q1 2026
2026-05-15 Korean
[기재정정]주식소각결정
Share Issue/Capital Change Classification · 95% confidence The document is a detailed announcement regarding the decision to cancel (소각) treasury shares (자기주식 소각 결정). It includes specifics such as the number and type of shares to be canceled, the total amount, dates of board resolutions, and shareholder meeting approvals. The document is not a full financial report but a corporate action announcement related to share capital changes. It is not a report publication announcement since it contains substantive details about the share cancellation. This fits the category of a Share Issue/Capital Change (SHA) filing, which covers announcements about share cancellations, stock splits, or other capital structure changes.
2026-04-30 Korean
[기재정정]타법인주식및출자증권취득결정
M&A Activity Classification · 85% confidence The document is a corporate disclosure by Access Bio detailing its decision to acquire shares and capital securities of another company ((주)알에프바이오), including transaction size, purpose, ownership percentages, timetables, and approvals. This is a strategic acquisition/takeover announcement rather than issuing new shares of the company itself, repurchasing its own shares, or simply notifying publication of a separate report. It falls squarely under M&A Activity announcements covering takeover bids or acquisition decisions.
2026-04-15 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 96% confidence The document is the formal results of the Annual General Meeting (정기주주총회 결과), showing detailed vote outcomes on each resolution, percentages for approval, and related meeting decisions. This is not an announcement of an attached report nor a full annual or interim financial statement. It clearly matches a Declaration of Voting Results & Voting Rights Announcement (DVA).
2026-03-31 Korean
본점소재지변경
Regulatory Filings Classification · 75% confidence The document is a notification of the company’s change of registered head office address. It does not present financial results, audit opinions, dividend details, share transactions, or AGM materials, nor is it a formal report publication announcement. There is no specific category for office relocation notices, so it falls into the general regulatory announcement category.
2026-03-31 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 87% confidence The document is a formal notification to the Korean Financial Services Commission and Korea Exchange regarding the appointment (“선임”), dismissal, or mid-term resignation of outside directors (“사외이사”). It provides details of the board change, including names, dates, and profiles of newly appointed outside directors. This clearly falls under Board/Management Information, which covers announcements of changes in a company’s board of directors or senior management.
2026-03-31 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.